AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteGap 27 is a peptide derived from connexin 43 that is a selective gap junction blocker.
More Information Supplier PageGAP-134 , a small modified dipeptide, has been identified as a potent and selective second generation gap junction modifier with oral bioavailability.
More Information Supplier PageGAP-134 , a small modified dipeptide, has been identified as a potent and selective second generation gap junction modifier with oral bioavailability.
More Information Supplier PageGAP-134 , a small modified dipeptide, has been identified as a potent and selective second generation gap junction modifier with oral bioavailability.
More Information Supplier PageGAP-134 Hydrochloride, a small modified dipeptide, has been identified as a potent and selective second generation gap junction modifier with oral bioavailability.
More Information Supplier PageGAP-134 Hydrochloride, a small modified dipeptide, has been identified as a potent and selective second generation gap junction modifier with oral bioavailability.
More Information Supplier PageGAP-134 Hydrochloride, a small modified dipeptide, has been identified as a potent and selective second generation gap junction modifier with oral bioavailability.
More Information Supplier PageGastrodin (Gastrodine) is a polyphenol. It is the glucoside of 4-hydroxybenzyl alcohol (gastrodigenin).
More Information Supplier PageGastrodin (Gastrodine) is a polyphenol. It is the glucoside of 4-hydroxybenzyl alcohol (gastrodigenin).
More Information Supplier PageGastrodin (Gastrodine) is a polyphenol. It is the glucoside of 4-hydroxybenzyl alcohol (gastrodigenin).
More Information Supplier PageGastrodin (Gastrodine) is a polyphenol. It is the glucoside of 4-hydroxybenzyl alcohol (gastrodigenin).
More Information Supplier PageGastrodin (Gastrodine) is a polyphenol. It is the glucoside of 4-hydroxybenzyl alcohol (gastrodigenin).
More Information Supplier PageGatifloxacin is a fluoroquinolone antibiotic which inhibits bacterial DNA gyrase (IC50 = 0.109 ng/ml) and topoisomerase IV (IC50 = 13.8 ng/ml).
More Information Supplier PageGatifloxacin is a fluoroquinolone antibiotic which inhibits bacterial DNA gyrase (IC50 = 0.109 ng/ml) and topoisomerase IV (IC50 = 13.8 ng/ml).
More Information Supplier PageGatifloxacin is a fluoroquinolone antibiotic which inhibits bacterial DNA gyrase (IC50 = 0.109 ng/ml) and topoisomerase IV (IC50 = 13.8 ng/ml).
More Information Supplier PageGatifloxacin is a fluoroquinolone antibiotic which inhibits bacterial DNA gyrase (IC50 = 0.109 ng/ml) and topoisomerase IV (IC50 = 13.8 ng/ml).
More Information Supplier PageGBR 12783 dihydrochloride is a very potent and selective inhibitor of dopamine uptake (IC50 for inhibition of [3H]-dopamine uptake in rat striatal synaptosomes is 1.8 nM).
More Information Supplier PageGBR 12783 dihydrochloride is a very potent and selective inhibitor of dopamine uptake (IC50 for inhibition of [3H]-dopamine uptake in rat striatal synaptosomes is 1.8 nM).
More Information Supplier PageGBR 12783 dihydrochloride is a very potent and selective inhibitor of dopamine uptake (IC50 for inhibition of [3H]-dopamine uptake in rat striatal synaptosomes is 1.8 nM).
More Information Supplier PageGBR-12935 is a piperazine derivative which is a potent and selective dopamine reuptake inhibitor.
More Information Supplier PageGBR-12935 is a piperazine derivative which is a potent and selective dopamine reuptake inhibitor.
More Information Supplier PageGBR-12935 is a piperazine derivative which is a potent and selective dopamine reuptake inhibitor.
More Information Supplier PageGDC-0032 is a potent, next-generation PI3 inhibitor targeting PI3 alpha.
More Information Supplier PageGDC-0032 is a potent, next-generation PI3 inhibitor targeting PI3 alpha.
More Information Supplier PageGDC-0032 is a potent, next-generation PI3 inhibitor targeting PI3 alpha.
More Information Supplier PageGDC-0032 is a potent, next-generation PI3 inhibitor targeting PI3 alpha.
More Information Supplier PageGDC-0068 is an ATP-competitive small molecule inhibitor of all three isoforms of Akt
More Information Supplier PageGDC-0068 is an ATP-competitive small molecule inhibitor of all three isoforms of Akt
More Information Supplier PageGDC-0068 is an ATP-competitive small molecule inhibitor of all three isoforms of Akt
More Information Supplier PageGDC-0068 is an ATP-competitive small molecule inhibitor of all three isoforms of Akt
More Information Supplier PageGDC-0152 is a second mitochondrial activator of caspases (Smac) mimetic inhibitor of IAPs (Inhibitor of Apoptosis Proteins) with potential antineoplastic activity.
More Information Supplier PageGDC-0152 is a second mitochondrial activator of caspases (Smac) mimetic inhibitor of IAPs (Inhibitor of Apoptosis Proteins) with potential antineoplastic activity.
More Information Supplier PageGDC-0152 is a second mitochondrial activator of caspases (Smac) mimetic inhibitor of IAPs (Inhibitor of Apoptosis Proteins) with potential antineoplastic activity.
More Information Supplier PageGDC-0152 is a second mitochondrial activator of caspases (Smac) mimetic inhibitor of IAPs (Inhibitor of Apoptosis Proteins) with potential antineoplastic activity.
More Information Supplier PageGDC-0349 is under evaluating the Safety and Tolerability in Patients with locally advanced or metastatic solid tumors or non hodgkin’s lymphoma.
More Information Supplier PageGDC-0349 is under evaluating the Safety and Tolerability in Patients with locally advanced or metastatic solid tumors or non hodgkin’s lymphoma.
More Information Supplier PageGDC-0349 is under evaluating the Safety and Tolerability in Patients with locally advanced or metastatic solid tumors or non hodgkin’s lymphoma.
More Information Supplier PageGDC-0349 is under evaluating the Safety and Tolerability in Patients with locally advanced or metastatic solid tumors or non hodgkin’s lymphoma.
More Information Supplier PageGDC-0349 is under evaluating the Safety and Tolerability in Patients with locally advanced or metastatic solid tumors or non hodgkin’s lymphoma.
More Information Supplier PageGDC-0449 (Vismodegib) is a more potent novel and specific synthetic oral hedgehog pathway inhibitor with an IC50 of 3 nM.
More Information Supplier Page
